Churchill Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-35,144
Closed -$10.5M 194
2015
Q1
$10.5M Buy
35,144
+4,805
+16% +$1.37M 0.36% 39
2014
Q4
$7.81M Buy
30,339
+4,674
+18% +$1.17M 0.31% 37
2014
Q3
$6.19M Buy
25,665
+23,136
+915% +$5.18M 0.25% 54
2014
Q2
$564K Sell
2,529
-137
-5% -$28.4K 0.03% 148
2014
Q1
$549K Buy
2,666
+21
+0.8% +$4.16K 0.02% 147
2013
Q4
$444K Hold
2,645
0.02% 152
2013
Q3
$381K Hold
2,645
0.02% 151
2013
Q2
$334K Buy
+2,645
New +$299K 0.02% 154

Other funds holding AGN

Churchill Management's AGN Position: Q2 2015 in Review

Churchill Management sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 35,144 shares — an estimated $10.5M sold.

Churchill Management first reported a position in AGN in Q2 2013 and held it in 8 quarters. The position peaked at $10.5M in Q1 2015. 1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Churchill Management reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
  • Churchill Management sold 35,144 Allergan plc shares in Q2 2015, an estimated $10.5M.
  • Churchill Management first reported a position in Allergan plc in Q2 2013 and held it in 8 quarters.
  • Churchill Management's Allergan plc position peaked at $10.5M in Q1 2015.
  • 1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Churchill Management's 13F filing for Q2 2015, filed 22 Jul 2015.